🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 185063104
- Market Cap
- Small Cap · $178 Million
- IPO
- 6/2/2016 · $7.00/share
Business: Clearside Biomedical, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics to treat blinding diseases of the eye, including diseases affecting the choroid and retina. It develops drug therapies using its microinjector to reach diseased tissue through the suprachoroidal space (SCS). Its areas of focus include advancing its CLS-1002 age-related wet macular degeneration (AMD) development program, developing a product candidate to treat diabetic macular edema (DME) and developing therapies through collaborations with third parties.
Company Contact
- CEO
- George Lasezkay
- CFO
- Charles A. Deignan
- Headquarters
- 900 North Point Parkway, Suite 200, Alpharetta, GA 30005
- Phone
- 678-270-3631
- Investor Relations
- Charlie Deignan · 678-270-4005 · charlie.deignan@clearsidebio.com